Définition de la dénutrition????, p.46 ,
, Critère de jugement principal????????????????????, p.46
, Critères de jugement secondaires, p.46
, Caractéristiques de la population incluse????????????????, vol.48, p.57
, -La réponse au traitement par immunothérapie selon les critères RECIST version 1.1 -Les effets indésirables secondaire à l'immunothérapie
Estimation nationale de l'incidence et de la mortalité par cancer en France entre 1980 et 2012 : Etude à partir des registres des cancers du réseau Francim. Partie 1 -Tumeurs solides, 2013. ,
Global cancer statistics, 2012: Global Cancer Statistics, CA Cancer J Clin. mars, vol.65, issue.2, pp.87-108, 2012. ,
, Projection de l'incidence et de la mortalité par cancer en France métropolitaine en 2017, p.80
Survie des personnes atteintes de cancer en France métropolitaine 1983-2013 -Etude à partir des registres des cancers du réseau Francim. Partie 1 -Tumeurs solides, Synthère. févr, 2016. ,
The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer, J Thorac Oncol Off Publ Int Assoc Study Lung Cancer. janv, vol.11, issue.1, pp.39-51, 2016. ,
Lung Cancer: Epidemiology, Etiology, and Prevention, Clin Chest Med. déc, vol.32, issue.4, pp.605-649, 2011. ,
A Risk Model for Prediction of Lung Cancer, JNCI J Natl Cancer Inst. 2 mai, vol.99, issue.9, pp.715-741, 2007. ,
Urban Air Pollution and Lung Cancer in Stockholm, vol.11, p.9, 2000. ,
The global burden of disease due to occupational carcinogens, Am J Ind Med. déc, vol.48, issue.6, pp.419-450, 2005. ,
Asbestosis: A Marker for the Increased Risk of Lung Cancer Among Workers Exposed to Asbestos, Chest. févr, vol.115, issue.2, pp.536-585, 1999. ,
International trends in lung cancer incidence by histological subtype: Adenocarcinoma stabilizing in men but still increasing in women, Lung Cancer. avr, vol.84, issue.1, pp.13-22, 2014. ,
Lung cancer in never smokers -a different disease, Nat Rev Cancer, vol.7, issue.10, pp.778-90, 2007. ,
Initial Evaluation of the Patient With Lung Cancer: Symptoms, Signs, Laboratory Tests, and Paraneoplastic Syndromes, Chest. sept, vol.132, issue.3, pp.149-160, 2007. ,
Référentiel en oncologie Auvergne -Rhône-Alpes. Cancer bronchique non à petites cellules. 14ème édition, p.57 ,
The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer, J Thorac Oncol. juill, vol.10, issue.7, pp.990-1003, 2015. ,
The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer, J Thorac Oncol. déc, vol.10, issue.12, pp.1675-84, 2015. ,
The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the M Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer, J Thorac Oncol, vol.10, issue.11, pp.1515-1537, 2015. ,
Immunotherapy for lung cancer: Immunotherapy for lung cancer, Respirology. juill, vol.21, issue.5, pp.821-854, 2016. ,
Oncology Meets Immunology: The Cancer-Immunity Cycle, Immunity. juill, vol.39, issue.1, pp.1-10, 2013. ,
Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation, J Exp Med. 1 mars, vol.173, issue.3, pp.721-751, 1991. ,
CTLA-4 is a second receptor for the B cell activation antigen B7, J Exp Med. 1 sept, vol.174, issue.3, pp.561-570, 1991. ,
Ipilimumab in Combination With Paclitaxel and Carboplatin As First-Line Treatment in Stage IIIB/IV Non-Small-Cell Lung Cancer: Results From a Randomized, Double-Blind, Multicenter Phase II Study, J Clin Oncol. 10 juin, vol.30, issue.17, pp.2046-54, 2012. ,
Phase III Trial of Ipilimumab Combined With Paclitaxel and Carboplatin in Advanced Squamous Non-Small-Cell Lung Cancer, J Clin Oncol, vol.35, issue.30, pp.3449-57, 2017. ,
Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer, N Engl J Med, vol.28, 2019. ,
Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation, J Exp Med, vol.192, issue.7, pp.1027-1061, 2000. ,
Tumorassociated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion, Nat Med. août, vol.8, issue.8, pp.793-800, 2002. ,
High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation, Med Oncol. sept, vol.28, issue.3, pp.682-690, 2011. ,
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer, N Engl J Med. 9 juill, vol.373, issue.2, pp.123-158, 2015. ,
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer, N Engl J Med, vol.373, issue.17, pp.1627-1666, 2015. ,
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial, The Lancet. avr, vol.387, pp.1540-50, 2016. ,
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer, N Engl J Med, vol.375, issue.19, pp.1823-1856, 2016. ,
Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial. The Lancet, vol.393, pp.1819-1849, 2019. ,
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer, N Engl J Med. 31 mai, vol.378, issue.22, pp.2078-92, 2018. ,
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer, N Engl J Med, vol.379, issue.21, pp.2040-51, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02345238
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer, N Engl J Med, vol.377, issue.20, pp.1919-1948, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01753457
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC, N Engl J Med. 13 déc, vol.379, issue.24, pp.2342-50, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-02284390
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial. The Lancet, vol.389, pp.255-65, 2017. ,
Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study, Lancet Oncol. nov, vol.19, issue.11, pp.1468-79, 2018. ,
Skin Reactions to Immune Checkpoint Inhibitors, Naing A, Hajjar J, éditeurs. Immunotherapy, pp.175-84, 2017. ,
Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis, JAMA Oncol. 1 févr, vol.4, issue.2, p.173, 2018. ,
Incidence of Programmed Cell Death 1 Inhibitor-Related Pneumonitis in Patients With Advanced Cancer: A Systematic Review and Meta-analysis, JAMA Oncol. 1 déc, vol.2, issue.12, p.1607, 2016. ,
Safety and Tolerability of Immune Checkpoint Inhibitors (PD-1 and PD-L1) in Cancer, Drug Saf. févr, vol.42, issue.2, pp.281-94, 2019. ,
Evaluation diagnostique de la dénutrition protéino-énergétique des adultes hospitalisés, Acta Endosc. sept, vol.28, issue.2, pp.151-156, 2003. ,
Pathophysiological factors of importance in proteincalorie malnutrition, Br Med Bull. janv, vol.28, issue.1, pp.72-80, 1972. ,
, The Lancet, 1933.
Malnutrition Diagnoses in Hospitalized Patients: United States, J Parenter Enter Nutr. févr, vol.38, issue.2, pp.186-95, 2010. ,
Prognostic impact of disease-related malnutrition, Clin Nutr. févr, vol.27, issue.1, pp.5-15, 2008. ,
Social risk factors for hospital malnutrition, Nutrition. mars, vol.21, issue.3, pp.295-300, 2005. ,
, Stratégie de prise en charge en cas de dénutrition protéino-énergétique chez la personne âgée. HAS, 2007.
Academy Malnutrition Work Group, et al. Consensus Statement: Academy of Nutrition and Dietetics and American Society for Parenteral and Enteral Nutrition: Characteristics Recommended for the Identification and Documentation of Adult Malnutrition (Undernutrition), J Parenter Enter Nutr. mai, vol.36, issue.3, pp.275-83, 2012. ,
Diagnostic criteria for malnutrition -An ESPEN Consensus Statement, Clin Nutr. juin, vol.34, issue.3, pp.335-375, 2015. ,
1874) the average man and indices of obesity, Nephrol Dial Transplant. 17 août, vol.23, issue.1, pp.47-51, 1796. ,
, Physical status: the use and interpretation of anthropometry, World Health Organ Tech Rep Ser, vol.854
Percentage of weight loss, a basic indicators of surgical risk in patients with chronic peptic ulcer, JAMA. 8 févr, vol.106, issue.6, pp.458-60, 1936. ,
Prognostic effect of weight loss prior tochemotherapy in cancer patients, Am J Med, vol.69, issue.4, pp.491-498, 1980. ,
Time-Dependent Variation in Weight and Body Composition in Healthy Adults, J Parenter Enter Nutr. mars, vol.24, issue.2, pp.52-57, 2000. ,
The assessment of weight loss from a single measurement of body weight: the problems and limitations, Am J Clin Nutr, vol.33, pp.2101-2106, 1980. ,
Human serum albumin: From bench to bedside, Mol Aspects Med. juin, vol.33, issue.3, pp.209-90, 2012. ,
Prognosis in 41 severely malnourished anorexia nervosa patients, Clin Nutr, vol.31, issue.5, pp.693-701, 2012. ,
The Biology of Human Starvation I-II, 1950. ,
Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury, The Lancet. 6 avr, pp.781-785, 1985. ,
Interleukin 2-induced increase of vascular permeability without decrease of the intravascular albumin pool, Br J Cancer. janv, vol.71, issue.1, pp.78-82, 1995. ,
Hypoalbuminemia in Acute Illness: Is There a Rationale for Intervention?: A Meta-Analysis of Cohort Studies and Controlled Trials, Ann Surg. mars, vol.237, issue.3, pp.319-353, 2003. ,
Electrophoretic study of the blood protein response in tuberculosis, J Biol Chem, vol.143, pp.29-38, 1942. ,
The Amino Acid Sequence of Human Plasma Prealbumin, p.11 ,
Cellular origin of prealbumin in the rat, Biochim Biophys Acta BBA -Gen Subj. juin, vol.716, issue.3, pp.446-455, 1982. ,
Localization of human prealbumin in choroid plexus epithelium, J Histochem Cytochem. mai, vol.31, issue.5, pp.608-620, 1983. ,
Preparation of I-131-labeled human serum prealbumin and its metabolism in normal and sick patients, J Clin Invest, vol.44, issue.10, pp.1600-1609, 1965. ,
The effects of diseases of the liver, thyroid, and kidneys on the transport of vitamin A in human plasma, J Clin Invest, vol.50, issue.11, pp.2426-2462, 1971. ,
Transthyretin: a multifaceted protein, Biomol Concepts. 1 janv, vol.5, issue.1, 2014. ,
Measurement of prealbumin as index of protein-calorie malnutrition. The Lancet. 15 juill 1972, pp.106-115 ,
The acute phase protein response in patients receiving subcutaneous IL-6, Clin Exp Immunol. 28 juin, vol.102, issue.1, pp.217-240, 2008. ,
Nutrition-related risk indexes and long-term mortality in noncritically ill inpatients who receive total parenteral nutrition (prospective multicenter study), Clin Nutr, vol.34, issue.5, pp.962-969, 2015. ,
Assessing the Nutritional Status of the Elderly: The Mini Nutritional Assessment as Part of the Geriatric Evaluation, Nutr Rev. 27 avr, vol.54, issue.1, pp.59-65, 2009. ,
Screening for Undernutrition in Geriatric Practice: Developing the Short-Form Mini-Nutritional Assessment (MNA-SF), J Gerontol A Biol Sci Med Sci. 1 juin, vol.56, issue.6, pp.366-72, 2001. ,
Does the Mini Nutritional Assessment predict hospitalization outcomes in older people, p.6 ,
Aging, Total Body Potassium, Fat-free Mass, and Cell Mass in Males and Females Between Ages 18 and 85 Years, J Gerontol, vol.27, issue.4, pp.438-481, 1972. ,
Fat-free mass index and fat mass index percentiles in Caucasians aged 18-98, Int J Obes. juill, vol.26, issue.7, pp.953-60, 2002. ,
Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 Years, Br J Nutr. juill, vol.32, issue.01, pp.77-97, 1974. ,
Bioelectrical impedance analysis?part I: review of principles and methods, Clin Nutr, vol.23, issue.5, pp.1226-1269, 2004. ,
European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People, Age Ageing. 1 juill, vol.39, issue.4, pp.412-435, 2010. ,
Advanced body composition assessment: from body mass index to body composition profiling, J Investig Med. juin, vol.66, issue.5, pp.1-10, 2018. ,
Prevalence of Malnutrition and Current Use of Nutrition Support in Patients With Cancer, J Parenter Enter Nutr. févr, vol.38, issue.2, pp.196-204, 2014. ,
Protein Energy Malnutrition Decreases Immunity and Increases Susceptibility to Influenza Infection in Mice, J Infect Dis. 1 févr, vol.207, issue.3, pp.501-511, 2013. ,
Flow Cytometry Study of Lymphocyte Subsets in Malnourished and Well-Nourished Children with Bacterial Infections, Clin Vaccine Immunol. 1 mai, vol.11, issue.3, pp.577-80, 2004. ,
Effect of Malnutrition on the Expression of Cytokines Involved in Th1 Cell Differentiation, Nutrients. 19 févr, vol.5, issue.2, pp.579-93, 2013. ,
Expression of Cytokine mRNA in Lymphocytes of Malnourished Children, J Clin Immunol. sept, vol.28, issue.5, pp.593-602, 2008. ,
The effects of dietary restriction on immune function and development of autoimmune disease in BXSB mice, Proc Natl Acad Sci. 1 avr, vol.89, issue.7, pp.3145-3154, 1992. ,
Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis, J Leukoc Biol, vol.84, issue.4, pp.940-948, 2008. ,
Expression of ob mRNA and its encoded protein in rodents. Impact of nutrition and obesity, J Clin Invest. 1 sept, vol.96, issue.3, pp.1658-63, 1995. ,
Role of leptin in the neuroendocrine response to fasting, Nature. 18 juill, vol.382, pp.250-252, 1996. ,
Diagnostic Criteria for the Classification of Cancer-Associated Weight Loss, J Clin Oncol. janv, vol.33, issue.1, pp.90-99, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-02276651
Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review, Eur J Cancer. avr, vol.57, pp.58-67, 2016. ,
Nutritional Status Affects Treatment Tolerability and Survival in Metastatic Colorectal Cancer Patients: Results of an AGEO Prospective Multicenter Study, Oncology, vol.81, issue.5-6, pp.395-402, 2011. ,
Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers?, Br J Cancer. mai, vol.90, issue.10, pp.1905-1916, 2004. ,
Baseline Nutritional Status Is Predictive of Response to Treatment and Survival in Patients Treated by Definitive Chemoradiotherapy for a Locally Advanced Esophageal Cancer, Am J Gastroenterol, vol.102, issue.11, pp.2557-63, 2007. ,
Impact of Weight Loss at Presentation on Survival in Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR-TKI) Sensitive Mutant Advanced Non-small Cell Lung Cancer (NSCLC) Treated with First-line EGFR-TKI, J Cancer, vol.9, issue.3, pp.528-562, 2018. ,
Does sarcopenia affect outcome in patients with non-small-cell lung cancer harboring EGFR mutations?, Future Oncol. avr, vol.14, issue.10, pp.919-945, 2018. ,
Treatment status and safety of crizotinib in 2028 Japanese patients with ALK-positive NSCLC in clinical settings, Jpn J Clin Oncol. 1 juill, vol.49, issue.7, pp.676-86, 2019. ,
Predictive value of skeletal muscle mass for immunotherapy with nivolumab in nonsmall cell lung cancer patients: A "hypothesis-generator" preliminary report: Sarcopenia in NSCLC, Thorac Cancer. févr, vol.10, issue.2, pp.347-51, 2019. ,
Association of Sarcopenia with and Efficacy of Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer, J Clin Med. 3 avr, vol.8, issue.4, p.450, 2019. ,
Impact of sarcopenia in patients with advanced non-small cell lung cancer treated with PD-1 inhibitors: A preliminary retrospective study, Sci Rep. déc, vol.9, issue.1, 2019. ,
Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients, Invest New Drugs. août, vol.35, issue.4, pp.436-477, 2017. ,
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1), Eur J Cancer. janv, vol.45, issue.2, pp.228-275, 2009. ,
Undernutrition screening survey in 564,063 patients: patients with a positive undernutrition screening score stay in hospital 1.4 d longer, Am J Clin Nutr. 1 avr, vol.103, issue.4, pp.1026-1058, 2016. ,
Prevalence, risk factors and clinical implications of malnutrition in French Comprehensive Cancer Centres, Br J Cancer. mars, vol.102, issue.6, pp.966-71, 2010. ,
The IASLC Lung Cancer Staging Project: The New Database to Inform the Eighth Edition of the TNM Classification of Lung Cancer, J Thorac Oncol, vol.9, issue.11, pp.1618-1642, 2014. ,
Prevalence and risk factors of malnutrition among cancer patients according to tumor location and stage in the National Cancer Center in Korea, Nutrition. mars, vol.26, issue.3, pp.263-271, 2010. ,
Pembrolizumab for the Treatment of Non-Small-Cell Lung Cancer, N Engl J Med. 21 mai, vol.372, issue.21, pp.2018-2046, 2015. ,
Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057), J Clin Oncol. 10 déc, vol.35, issue.35, pp.3924-3957, 2017. ,
Clinical and Molecular Characteristics Associated With Survival Among Patients Treated With Checkpoint Inhibitors for Advanced Non-Small Cell Lung Carcinoma: A Systematic Review and Meta-analysis, JAMA Oncol. 1 févr, vol.4, issue.2, p.210, 2018. ,
Sub-cutaneous Fat Mass measured on multislice computed tomography of pretreatment PET/CT is a prognostic factor of stage IV non-small cell lung cancer treated by nivolumab, OncoImmunology. 4 mai, vol.8, issue.5, p.1580128, 2019. ,
URL : https://hal.archives-ouvertes.fr/hal-02342305
Interactions between adipose tissue and the immune system in health and malnutrition, Semin Immunol. sept, vol.27, issue.5, pp.322-355, 2015. ,
Cancer-associated cachexia, Nat Rev Dis Primer. juin, vol.4, issue.1, 2018. ,